Director/PDMR Shareholding
12 June 2024 Transaction by Person Discharging Managerial Responsibilities AstraZeneca PLC (the Company) announces that, on 10 June 2024, it was notified by Pascal Soriot, Chief Executive Officer, that, on 10 June 2024, Mr Soriot ceased to be beneficially interested in 297,418 Ordinary Shares of $0.25 each in the Company, following the gift of those shares to family members for nil consideration. Further details are set out in the attached notification, made in accordance with the requirements of the EU Market Abuse Regulation (as it forms part of UK law pursuant to the European